Aardvark Therapeutics, Inc. (AARD)
12.30
-0.11
(-0.89%)
USD |
NASDAQ |
Feb 20, 16:00
12.30
0.00 (0.00%)
After-Hours: 20:00
Aardvark Therapeutics EPS Diluted (Quarterly) : -0.7503 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Insmed, Inc. | -1.538 |
| Soleno Therapeutics, Inc. | 0.4736 |
| Rhythm Pharmaceuticals, Inc. | -0.8192 |
| Definium Therapeutics, Inc. | -0.7832 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.32M |
| Total Expenses (Quarterly) | 16.32M |
| Enterprise Value | 144.40M |
| Earnings Yield | -18.26% |
| Normalized Earnings Yield | -18.26 |